Mateu M, Valbuena A
Subcell Biochem. 2024; 105:823-878.
PMID: 39738964
DOI: 10.1007/978-3-031-65187-8_22.
Omole A, Zhao Z, Chang-Liao S, de Oliveira J, Boone C, Sutorus L
Nat Rev Bioeng. 2024; 2(11):916-929.
PMID: 39698315
PMC: 11655125.
DOI: 10.1038/s44222-024-00231-z.
Keshavarz-Joud P, Zhao L, Bobe D, Hernandez C, Kopylov M, Yen L
ACS Nano. 2023; 17(18):18470-18480.
PMID: 37669408
PMC: 10540251.
DOI: 10.1021/acsnano.3c06178.
Holz E, Darwish M, Tesar D, Shatz-Binder W
Pharmaceutics. 2023; 15(2).
PMID: 36839922
PMC: 9959917.
DOI: 10.3390/pharmaceutics15020600.
Mejia-Mendez J, Vazquez-Duhalt R, Hernandez L, Sanchez-Arreola E, Bach H
Int J Mol Sci. 2022; 23(15).
PMID: 35955711
PMC: 9369363.
DOI: 10.3390/ijms23158579.
Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms.
Jafari A, Pouya F, Niknam Z, Abdollahpour-Alitappeh M, Rezaei-Tavirani M, Rasmi Y
Mol Biol Rep. 2022; 49(6):4943-4957.
PMID: 35235159
PMC: 8890022.
DOI: 10.1007/s11033-022-07132-7.
Application of Plant Viruses in Biotechnology, Medicine, and Human Health.
Venkataraman S, Hefferon K
Viruses. 2021; 13(9).
PMID: 34578279
PMC: 8473230.
DOI: 10.3390/v13091697.
Frontiers in Bioengineering and Biotechnology: Plant Nanoparticles for Anti-Cancer Therapy.
Shoeb E, Badar U, Venkataraman S, Hefferon K
Vaccines (Basel). 2021; 9(8).
PMID: 34451955
PMC: 8402531.
DOI: 10.3390/vaccines9080830.
Single-Point Mutations in Qβ Virus-like Particles Change Binding to Cells.
Martino M, Crooke S, Manchester M, Finn M
Biomacromolecules. 2021; 22(8):3332-3341.
PMID: 34251176
PMC: 9068229.
DOI: 10.1021/acs.biomac.1c00443.
Self-assembled Viral Nanoparticles as Targeted Anticancer Vehicles.
Wu Y, Li J, Shin H
Biotechnol Bioprocess Eng. 2021; 26(1):25-38.
PMID: 33584104
PMC: 7872722.
DOI: 10.1007/s12257-020-0383-0.
The pharmacology of plant virus nanoparticles.
Nkanga C, Steinmetz N
Virology. 2021; 556:39-61.
PMID: 33545555
PMC: 7974633.
DOI: 10.1016/j.virol.2021.01.012.
Nano drug delivery systems in upper gastrointestinal cancer therapy.
Salapa J, Bushman A, Lowe K, Irudayaraj J
Nano Converg. 2020; 7(1):38.
PMID: 33301056
PMC: 7728832.
DOI: 10.1186/s40580-020-00247-2.
Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?.
Gurunathan S, Qasim M, Choi Y, Do J, Park C, Hong K
Nanomaterials (Basel). 2020; 10(9).
PMID: 32825737
PMC: 7557932.
DOI: 10.3390/nano10091645.
Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses.
Alam M, Jarvis C, Hincapie R, McKay C, Schimer J, Sanhueza C
ACS Nano. 2020; 15(1):309-321.
PMID: 32790346
PMC: 8249087.
DOI: 10.1021/acsnano.0c03023.
Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications.
Chung Y, Cai H, Steinmetz N
Adv Drug Deliv Rev. 2020; 156:214-235.
PMID: 32603813
PMC: 7320870.
DOI: 10.1016/j.addr.2020.06.024.
Virus-like particle-based vaccines for animal viral infections.
Crisci E, Barcena J, Montoya M
Inmunologia. 2020; 32(3):102-116.
PMID: 32287712
PMC: 7115488.
DOI: 10.1016/j.inmuno.2012.08.002.
Nanoparticle Vaccines Against Infectious Diseases.
Pati R, Shevtsov M, Sonawane A
Front Immunol. 2018; 9:2224.
PMID: 30337923
PMC: 6180194.
DOI: 10.3389/fimmu.2018.02224.
TMV Particles: The Journey From Fundamental Studies to Bionanotechnology Applications.
Lomonossoff G, Wege C
Adv Virus Res. 2018; 102:149-176.
PMID: 30266172
PMC: 7112118.
DOI: 10.1016/bs.aivir.2018.06.003.
Synthesis at the interface of virology and genetic code expansion.
Kelemen R, Erickson S, Chatterjee A
Curr Opin Chem Biol. 2018; 46:164-171.
PMID: 30086446
PMC: 6446078.
DOI: 10.1016/j.cbpa.2018.07.015.
New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue.
Brune K, Howarth M
Front Immunol. 2018; 9:1432.
PMID: 29997617
PMC: 6028521.
DOI: 10.3389/fimmu.2018.01432.